Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (241)	3/17/2005 2:49:40 PM
From: Jibacoa	Read Replies (1) \| Respond to of 802

Well, after the strong performance yesterday afternoon the stock didn't need to test the $7 support today.<g> Although I am not particularly fond of the intra-day up-gaps it is showing in the last few minutes, I could not resist the temptation of buying a few Ks in view of the fact that the ASCO presentations are getting closer by the day.<g> bigcharts.marketwatch.com Bernard

To: tuck who wrote (241)	3/17/2005 3:38:25 PM
From: zeta1961	Read Replies (1) \| Respond to of 802

Tuck you make a good case for perhaps P3's not providing enough data for the subset..when the bears say they're not going well, it's very hard for me to gauge the accuracy since we don't know what accrual #'s are, which arm, etc... I'm also struck that Nance is keeping in line with his expectation he expressed several years ago(read this during a trial subscription to BioCentury who tracked INGN's and gene therapy's development in the early days) in which Nance said that he would expect to get Advexin approved with P2 data..(just remembered this last night) Tuck, CTIC...a big grrr, but glad you've eaked out a profit!!..it's my biggest blunder this year and in dollar terms..ever..Got out immediately..Pixantrone..I love what I've read about that molecule..from the thread here at SI, it sounds like the study results we know about were done by the other company..very much rooting for Xyotax and equivalency but don't have the stomach to ride the Bianco roller coaster..and I don't short or play options...learning the latter is at the top of my investing 'to do' list.. Going to ASCO again this year..very much looking forward to mixing it up with the INGN scientists<g> that's for you Bernard....been reading their names in these studies for almost 3 years now..I'd love it if Fisher presented, or Jack Roth..but these guys don't bother going sometimes and send their mentees<g>..Sunil Chada who seems to be doing much of the MDA-7 work should also be interesting..